| PERIOD ENDING | 30-Sep-08 | 30-Sep-07 | 30-Sep-06 | | Total Revenue | 10,414,500 | 10,037,800 | 8,850,400 | | Cost of Revenue | 7,693,100 | 7,361,600 | 6,558,300 | | | Gross Profit | 2,721,400 | 2,676,200 | 2,292,100 | | | Operating Expenses | | Research Development | 130,700 | 140,200 | 151,400 | | Selling General and Administrative | 1,120,700 | 1,204,600 | 1,080,700 | | Non Recurring | (35,600) | (36,800) | 67,500 | | Others | 9,800 | 16,600 |
-
| | | | Total Operating Expenses | 1,225,600 | 1,324,600 |
-
| | | | Operating Income or Loss | 1,495,800 | 1,351,600 | 992,500 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 56,100 | 68,400 | | Earnings Before Interest And Taxes | 1,640,800 | 1,539,500 | 1,168,600 | | Interest Expense | 162,000 | 163,200 | 119,300 | | Income Before Tax | 1,478,800 | 1,376,300 | 1,049,300 | | Income Tax Expense | 365,300 | 301,200 | 271,200 | | Minority Interest | (23,000) | (32,400) | (29,800) | | | | Net Income From Continuing Ops | 1,090,500 | 1,042,700 | 748,300 | | | Non-recurring Events | | Discontinued Operations | (180,800) | (7,100) | (18,700) | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| (6,200) | | Other Items |
-
|
-
|
-
| | | | Net Income | 909,700 | 1,035,600 | 723,400 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $909,700 | $1,035,600 | $723,400 |
|
1.48% Nasdaq 
Income Statement
